Joao Rafael Terneira Vicentini, M.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Femur | 2 | 2023 | 1311 | 0.660 |
Why?
|
| Tendon Entrapment | 1 | 2017 | 6 | 0.600 |
Why?
|
| Elbow Joint | 1 | 2022 | 359 | 0.600 |
Why?
|
| Femoracetabular Impingement | 1 | 2020 | 180 | 0.570 |
Why?
|
| Hallux | 1 | 2017 | 43 | 0.570 |
Why?
|
| Spondylosis | 1 | 2017 | 85 | 0.540 |
Why?
|
| Toes | 1 | 2017 | 209 | 0.540 |
Why?
|
| Magnetic Resonance Imaging | 10 | 2023 | 36849 | 0.480 |
Why?
|
| Bursitis | 1 | 2022 | 85 | 0.370 |
Why?
|
| Femur Head Necrosis | 1 | 2019 | 133 | 0.300 |
Why?
|
| De Quervain Disease | 1 | 2017 | 20 | 0.280 |
Why?
|
| Fluorodeoxyglucose F18 | 2 | 2022 | 2056 | 0.250 |
Why?
|
| Ankle | 1 | 2018 | 354 | 0.250 |
Why?
|
| Wrist Joint | 1 | 2017 | 267 | 0.240 |
Why?
|
| Tendon Injuries | 1 | 2018 | 329 | 0.240 |
Why?
|
| Osteoarthritis, Hip | 1 | 2019 | 409 | 0.240 |
Why?
|
| Bone Marrow | 1 | 2023 | 2929 | 0.210 |
Why?
|
| Fontan Procedure | 1 | 2018 | 805 | 0.200 |
Why?
|
| Anesthetics, Local | 1 | 2019 | 1004 | 0.200 |
Why?
|
| Rotation | 1 | 2023 | 517 | 0.190 |
Why?
|
| Ultrasonography | 2 | 2018 | 6001 | 0.180 |
Why?
|
| Rupture | 1 | 2022 | 444 | 0.170 |
Why?
|
| Liver Diseases | 1 | 2018 | 1304 | 0.170 |
Why?
|
| Bone Neoplasms | 1 | 2022 | 2565 | 0.170 |
Why?
|
| Glucocorticoids | 1 | 2019 | 2168 | 0.160 |
Why?
|
| Tendons | 1 | 2022 | 559 | 0.140 |
Why?
|
| Crohn Disease | 1 | 2020 | 2293 | 0.140 |
Why?
|
| Range of Motion, Articular | 1 | 2023 | 1599 | 0.130 |
Why?
|
| Pain | 1 | 2019 | 5103 | 0.110 |
Why?
|
| Hip Joint | 1 | 2020 | 1018 | 0.110 |
Why?
|
| Muscle, Skeletal | 1 | 2018 | 4981 | 0.110 |
Why?
|
| Tomography, X-Ray Computed | 3 | 2022 | 20765 | 0.110 |
Why?
|
| Multiple Myeloma | 1 | 2021 | 5192 | 0.110 |
Why?
|
| Bursa, Synovial | 1 | 2022 | 25 | 0.100 |
Why?
|
| Heart Defects, Congenital | 1 | 2018 | 4713 | 0.100 |
Why?
|
| Injections, Intra-Articular | 1 | 2022 | 288 | 0.090 |
Why?
|
| Contrast Media | 2 | 2020 | 5336 | 0.090 |
Why?
|
| Arthroscopy | 1 | 2017 | 971 | 0.090 |
Why?
|
| Female | 11 | 2023 | 397089 | 0.090 |
Why?
|
| Whole Body Imaging | 1 | 2022 | 284 | 0.090 |
Why?
|
| Computer Simulation | 1 | 2023 | 6277 | 0.080 |
Why?
|
| Humans | 15 | 2023 | 768393 | 0.080 |
Why?
|
| Triamcinolone | 1 | 2019 | 68 | 0.080 |
Why?
|
| Adult | 8 | 2023 | 223640 | 0.080 |
Why?
|
| Femur Head | 1 | 2019 | 297 | 0.070 |
Why?
|
| Retrospective Studies | 5 | 2022 | 81801 | 0.070 |
Why?
|
| Positron-Emission Tomography | 2 | 2022 | 6670 | 0.060 |
Why?
|
| Middle Aged | 6 | 2022 | 223491 | 0.060 |
Why?
|
| Elasticity Imaging Techniques | 1 | 2018 | 395 | 0.050 |
Why?
|
| Adrenal Cortex Hormones | 1 | 2022 | 1890 | 0.050 |
Why?
|
| Male | 7 | 2022 | 364902 | 0.050 |
Why?
|
| Feasibility Studies | 1 | 2023 | 5313 | 0.050 |
Why?
|
| Prospective Studies | 2 | 2022 | 54920 | 0.050 |
Why?
|
| Diagnosis, Differential | 1 | 2017 | 13020 | 0.050 |
Why?
|
| Radiopharmaceuticals | 1 | 2021 | 2734 | 0.050 |
Why?
|
| Radiography | 1 | 2019 | 6993 | 0.040 |
Why?
|
| Adipose Tissue | 1 | 2018 | 3334 | 0.030 |
Why?
|
| Neoplasm Staging | 1 | 2021 | 11254 | 0.030 |
Why?
|
| Pilot Projects | 1 | 2018 | 8731 | 0.030 |
Why?
|
| Comorbidity | 1 | 2019 | 10588 | 0.030 |
Why?
|
| Incidence | 1 | 2022 | 21544 | 0.030 |
Why?
|
| Neoplasm Recurrence, Local | 1 | 2021 | 9433 | 0.030 |
Why?
|
| Pandemics | 1 | 2022 | 8753 | 0.020 |
Why?
|
| Predictive Value of Tests | 1 | 2018 | 15455 | 0.020 |
Why?
|
| Young Adult | 2 | 2019 | 60049 | 0.020 |
Why?
|
| Disease Progression | 1 | 2019 | 13646 | 0.020 |
Why?
|
| Polymorphism, Single Nucleotide | 1 | 2020 | 16028 | 0.020 |
Why?
|
| Follow-Up Studies | 1 | 2019 | 39407 | 0.020 |
Why?
|
| Cross-Sectional Studies | 1 | 2018 | 26375 | 0.020 |
Why?
|
| Aged, 80 and over | 1 | 2019 | 59686 | 0.010 |
Why?
|
| Aged | 1 | 2019 | 171562 | 0.010 |
Why?
|